Xandra García‐González

647 total citations
33 papers, 449 citations indexed

About

Xandra García‐González is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Xandra García‐González has authored 33 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Xandra García‐González's work include Colorectal Cancer Treatments and Studies (10 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Genetic factors in colorectal cancer (4 papers). Xandra García‐González is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Genetic factors in colorectal cancer (4 papers). Xandra García‐González collaborates with scholars based in Spain, France and Switzerland. Xandra García‐González's co-authors include Luis A. López‐Fernández, María Sanjurjo‐Sáez, Pilar García‐Alfonso, María I. García, Luis Robles, Cristina Grávalos, Emilio Bouza, Alicia Galar, Patricia Muñóz and Almudena Burillo and has published in prestigious journals such as International Journal of Molecular Sciences, Antimicrobial Agents and Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

Xandra García‐González

29 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xandra García‐González Spain 14 204 113 87 63 51 33 449
Takahiro Shibayama Japan 12 135 0.7× 104 0.9× 120 1.4× 56 0.9× 63 1.2× 37 437
Mark Allison United States 9 137 0.7× 171 1.5× 65 0.7× 81 1.3× 115 2.3× 14 514
Rajendra Singh United States 11 89 0.4× 116 1.0× 57 0.7× 63 1.0× 83 1.6× 33 383
Matthew Hoffmann United States 13 118 0.6× 206 1.8× 71 0.8× 38 0.6× 37 0.7× 39 519
Marie‐Blanche Valnet‐Rabier France 13 83 0.4× 97 0.9× 86 1.0× 43 0.7× 47 0.9× 28 478
Toshiaki Nakamura Japan 13 115 0.6× 120 1.1× 44 0.5× 28 0.4× 24 0.5× 40 446
Anne‐Gaëlle Dosne Belgium 8 86 0.4× 83 0.7× 99 1.1× 66 1.0× 66 1.3× 19 406
Jiraphun Jittikoon Thailand 14 87 0.4× 133 1.2× 76 0.9× 115 1.8× 151 3.0× 51 614
Songmao Zheng United States 15 154 0.8× 190 1.7× 38 0.4× 44 0.7× 41 0.8× 35 762
Jacqueline L. Olin United States 13 92 0.5× 117 1.0× 28 0.3× 61 1.0× 41 0.8× 36 468

Countries citing papers authored by Xandra García‐González

Since Specialization
Citations

This map shows the geographic impact of Xandra García‐González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xandra García‐González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xandra García‐González more than expected).

Fields of papers citing papers by Xandra García‐González

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xandra García‐González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xandra García‐González. The network helps show where Xandra García‐González may publish in the future.

Co-authorship network of co-authors of Xandra García‐González

This figure shows the co-authorship network connecting the top 25 collaborators of Xandra García‐González. A scholar is included among the top collaborators of Xandra García‐González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xandra García‐González. Xandra García‐González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐González, Xandra, et al.. (2024). An Inexpensive and Quick Method for Genotyping of HLA Variants Included in the Spanish Pharmacogenomic Portfolio of National Health System. International Journal of Molecular Sciences. 25(20). 11207–11207.
2.
García‐González, Xandra, et al.. (2023). Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives. Journal of Personalized Medicine. 13(3). 385–385. 13 indexed citations
3.
García‐González, Xandra, et al.. (2023). Presence of metallic components in transdermal drug delivery systems and risk of skin burns. Farmacia Hospitalaria. 48(3). 129–132.
4.
García‐González, Xandra, et al.. (2023). Hacia la excelencia en la atención farmacéutica al paciente quirúrgico. Farmacia Hospitalaria. 47(1). 26–30. 2 indexed citations
5.
Trocóniz, Iñaki F., Santiago Grau, Nuria E. Campillo, et al.. (2022). Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy. Clinical Microbiology and Infection. 28(9). 1287.e9–1287.e15. 6 indexed citations
6.
García‐González, Xandra, et al.. (2021). PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort. Biomedicine & Pharmacotherapy. 146. 112519–112519. 14 indexed citations
7.
García‐González, Xandra, et al.. (2021). Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?. Journal of Personalized Medicine. 11(11). 1180–1180. 3 indexed citations
8.
García‐Alfonso, Pilar, Miriam Saiz‐Rodríguez, R. Mondéjar, et al.. (2021). Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines. Clinical & Translational Oncology. 24(3). 483–494. 31 indexed citations
9.
García‐González, Xandra, et al.. (2021). Clinical evaluation of pulmonary hypertension using patient-reported outcomes: a cross-sectional study. BMC Pulmonary Medicine. 21(1). 48–48. 1 indexed citations
10.
García‐González, Xandra, Fabienne Thomas, Pilar García‐Alfonso, et al.. (2020). New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine. Cancer Chemotherapy and Pharmacology. 86(1). 45–54. 15 indexed citations
11.
12.
Froehlich, Tanja K., Markus Joerger, Stefan Aebi, et al.. (2019). Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis. Pharmacological Research. 152. 104594–104594. 19 indexed citations
13.
García‐González, Xandra, Sara López‐Tarruella, María I. García, et al.. (2018). Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase <em>(DPYD)</em> gene. Cancer Management and Research. Volume 10. 4517–4522. 5 indexed citations
14.
García‐González, Xandra, María I. García, Pilar García‐Alfonso, et al.. (2018). Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan. Pharmacological Research. 136. 133–139. 19 indexed citations
15.
Galar, Alicia, Patricia Muñóz, Maricela Valerio, et al.. (2018). Current use of daptomycin and systematic therapeutic drug monitoring: Clinical experience in a tertiary care institution. International Journal of Antimicrobial Agents. 53(1). 40–48. 38 indexed citations
16.
Pellicer, Marta, Xandra García‐González, María I. García, et al.. (2017). Use of Exome Sequencing to Determine the Full Profile of Genetic Variants in the Fluoropyrimidine Pathway in Colorectal Cancer Patients Affected by Severe Toxicity. Pharmacogenomics. 18(13). 1215–1223. 11 indexed citations
17.
Pellicer, Marta, Xandra García‐González, María I. García, et al.. (2017). Identification of new SNPs associated with severe toxicity to capecitabine. Pharmacological Research. 120. 133–137. 39 indexed citations
18.
García‐González, Xandra, Teresa Cabaleiro, Marí­a José Herrero, Howard L. McLeod, & Luis A. López‐Fernández. (2016). Clinical implementation of pharmacogenetics. Drug Metabolism and Personalized Therapy. 31(1). 9–16. 18 indexed citations
19.
Escudero‐Vilaplana, Vicente, et al.. (2016). Impact of medication adherence on the effectiveness of deferasirox for the treatment of transfusional iron overload in myelodysplastic syndrome. Journal of Clinical Pharmacy and Therapeutics. 41(1). 59–63. 6 indexed citations
20.
García‐González, Xandra, María I. García, Pilar García‐Alfonso, et al.. (2015). Variants inCDAandABCB1are predictors of capecitabine-related adverse reactions in colorectal cancer. Oncotarget. 6(8). 6422–6430. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takahiro Shibayama Breakdown of academic impact, for papers by Mark Allison Breakdown of academic impact, for papers by Rajendra Singh Breakdown of academic impact, for papers by Matthew Hoffmann Breakdown of academic impact, for papers by Marie‐Blanche Valnet‐Rabier Breakdown of academic impact, for papers by Toshiaki Nakamura Breakdown of academic impact, for papers by Anne‐Gaëlle Dosne Breakdown of academic impact, for papers by Jiraphun Jittikoon Breakdown of academic impact, for papers by Songmao Zheng Breakdown of academic impact, for papers by Jacqueline L. Olin
Rankless by CCL
2026